KLM Axiva Finvest to raise up to INR 15,000 lakhs via non-convertible debentures

Kochi (Kerala) [India], August 28: KLM Axiva Finvest Ltd has announced the Company’s ninth public issue of secured redeemable non-convertible debentures with a face value of ₹Rs.1000. The base public issue size is ₹7,500 lakhs and the public issue limit will be with an option to retain over-subscription up to ₹7,500 lakhs, aggregating up to ₹15,000 lakhs with an option for additional subscription up to ₹Rs. 75 crores. The NCD issue opened on 24th August 2023 and will be closed on 6th September 2023.

The NCDs have ten different options for individual investors to choose from. Investors have 10 different options for applying in the NCD Issue. Effective yield Returns will be at the rates of the various investment options ranging from 9.38% to 11.02% p.a. On various investment options having face value is ₹Rs.1000, with multiple investment tenure options ranging from 400 days to 82 months and the minimum deposit amount is ₹Rs. 5,000 (5 NCDs).

All the previous public issues of KLM Axiva Finvest Ltd in the past were oversubscribed and have achieved minimum subscription. Investors can apply for NCDs through the branches of the Company and through BSE online platform. Application forms are available at https://klmaxiva.com/ncd, BSE India Official website and Vivro official website. All investors proposing to participate in the public issue of NCDs by KLM Axiva Finvest Limited should invest only on the basis of information contained in the Prospectus. Please see the section entitled “Risk Factors” beginning on page 17 of the Prospectus for risk in this regard.

‘Entire funds raised through the NCD will be utilized for onward lending, financing and repayment/prepayment of principal and interest on existing borrowings expansion of the gold loan business and widening of the branches across the country”, said Mr. T P Srinivasan, Chairman, KLM Axiva Finvest Ltd.

Kindly contact at +91-9961033333 for any further information regarding the Public Issue.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Related Posts

MotionGravity Develops Human Authenticity Registry to Bring Paid, Consent-Based AI Participation to Everyday People

HAR is being designed to help real people voluntarily participate in AI projects, verify consent through selective disclosure, and earn from eligible contributions while supporting authentic human-origin data for AI…

The Southern Bypass Comes of Age: Srijan Realty Launches Orizon to Anchor South Kolkata’s Urban Renaissance

Kolkata (West Bengal) [India], September 19: The Southern Bypass has systematically evolved from a peripheral transit route into one of South Kolkata’s most closely watched residential and lifestyle corridors. This…

You Missed

Essential Baby Travel Gear Every Parent Needs – Recommended by Loopie

  • By
  • September 19, 2026
Essential Baby Travel Gear Every Parent Needs – Recommended by Loopie

Wealthy Nivesh Multi-Asset FoF PMS Reaches 10-Month Milestone Across Volatile Market Cycles

  • By
  • September 19, 2026
Wealthy Nivesh Multi-Asset FoF PMS Reaches 10-Month Milestone Across Volatile Market Cycles

Engineers’ Day Celebrated at IPS Academy, Institute of Engineering and Science, Indore

  • By
  • September 19, 2026
Engineers’ Day Celebrated at IPS Academy, Institute of Engineering and Science, Indore

India International Jewellery Awards 2026 Receives Overwhelming Industry Response with Around 200 Nominations

  • By
  • September 19, 2026
India International Jewellery Awards 2026 Receives Overwhelming Industry Response with Around 200 Nominations

ICRAPAIN 2026 Brings 600 Plus Pain Professionals to Kolkata, Highlights Advances in Pain Biologics and Regenerative Medicine

ICRAPAIN 2026 Brings 600 Plus Pain Professionals to Kolkata, Highlights Advances in Pain Biologics and Regenerative Medicine

ODDS Longevity Concludes ‘The Silent Decade’ Symposium

  • By
  • September 18, 2026
ODDS Longevity Concludes ‘The Silent Decade’ Symposium